Google's Gemini 3 Is Here: A Special Early Look
Nytimes· 2025-11-18 16:00
Core Insights - The recent model release has garnered significant attention from competitors in the AI industry, indicating its potential impact on market dynamics [1] Group 1 - The model release may position the company at the forefront of the AI sector, suggesting a competitive advantage over rivals [1]
Google announces Gemini 3 as battle with OpenAI intensifies
CNBC· 2025-11-18 16:00
Core Insights - Google is launching its new AI model, Gemini 3, to enhance user experience by providing better answers to complex questions with less prompting [1][4] - The rollout of Gemini 3 will begin for select subscribers and expand to a broader audience in the coming weeks, following the previous versions Gemini 2.5 and 2.0 [2] - The Gemini app currently has 650 million monthly active users, while AI Overviews boasts 2 billion monthly users, indicating significant user engagement [3] Product Features - Gemini 3 is designed to understand depth and nuance, improving its ability to grasp context and intent behind user requests [4] - The AI responses from Gemini 3 aim to provide genuine insights rather than flattery, addressing criticisms of current AI chatbots being overly sycophantic [6] Industry Context - Major tech companies, including Alphabet, are heavily investing in AI infrastructure, with collective capital expenditures expected to exceed $380 billion this year [5] - OpenAI has also made advancements with its GPT-5 model, which has been updated to be more intelligent and efficient in task execution [7]
Microsoft unveils tool to help companies control, track AI agents
CNBC· 2025-11-18 16:00
Judson Althoff, CEO of Microsoft's commercial business and then mresident of Microsoft North America, speaks during We Day at KeyArena in Seattle on April 23, 2015.Microsoft made it easier for corporate workers to make AI agents that go off and do work. Now it's demonstrating a tool that IT specialists can use to see and manage those agents.The software, named Agent 365, provides a list of artificial intelligence agents inside companies' systems, even if they're from other companies, Microsoft announced Tue ...
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
Prnewswire· 2025-11-18 16:00
— Non-Cystic Fibrosis Bronchiectasis (NCFB) Is a Serious, Progressive Lung Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI Is a First-in-Disease, First-in-Class DPP1 Inhibitor Targeting Neutrophilic Inflammation — — BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — BRIDGEWATER, N.J., Nov. 18, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver firs ...
SofaBaton Launches the New-Generation X2 Universal Remote Featuring Premium Metal Build and Powerful IR Control
Globenewswire· 2025-11-18 16:00
HongKong, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The SofaBaton X2 is a new-generation universal remote that turns both hardware craftsmanship and IR performance up to eleven. Its body is built from a unibody zinc-alloy metal chassis with careful chamfer edges and a clean, well-spaced button layout. In the hand, the X2 feels substantial, with a distinct sense of weight and premium metal texture. The surface uses a refined sandblasted finish that resists fingerprints and provides a dry, non-slippery touch. The but ...
ALX Oncology to Present at Upcoming Investor Conferences
Globenewswire· 2025-11-18 16:00
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York. The details of the meetings are as follows: ...
Aetna Launches Leading Edge Conversational AI Navigation
Prnewswire· 2025-11-18 16:00
Accessibility StatementSkip Navigation Embedded assistant revolutionizes how members navigate their health care journey WOONSOCKET, R.I., Nov. 18, 2025 /PRNewswire/ -- Aetna, a CVS Health® company (NYSE: CVS), is launching a market-leading generative AI-powered conversational experience in its digital channels that will simplify health care, allowing members to quickly and easily navigate their benefits for a personalized experience. Nathan Frank, SVP and Aetna's Chief Digital and Technology officer stated, ...
Oshkosh Corporation to Participate in the UBS Global Industrials and Transportation Conference
Businesswire· 2025-11-18 16:00
Nov 18, 2025 11:00 AM Eastern Standard Time Oshkosh Corporation to Participate in the UBS Global Industrials and Transportation Conference Share OSHKOSH, Wis.--(BUSINESS WIRE)--Oshkosh Corporation (NYSE: OSK), a leading innovator of purpose- built vehicles, equipment and services, will participate in a fireside chat at the UBS Global Industrials and Transportation Conference. Presenting on behalf of Oshkosh will be President and CEO, John Pfeifer. The event is scheduled to start at 2:40 p.m. EST on December ...
Toronto Stock Exchange, Cavvy Energy Ltd., The View from the C-Suite
Newsfile· 2025-11-18 16:00
Toronto, Ontario--(Newsfile Corp. - November 18, 2025) - Darcy Reding, President and Chief Executive Officer, Cavvy Energy Ltd. (TSX: CVVY) ("Cavvy" or the "Company"), shares the Company's story in an interview with TMX Group.Cannot view this video? Visit:https://www.youtube.com/watch?v=MPtpkLm9AvcThe "View From The C-Suite" video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. These videos provide insight into how company executiv ...
ALX Oncology to Present at Upcoming Investor Conferences
Globenewswire· 2025-11-18 16:00
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York. The details of the meetings are as follows: ...